Insulin Resistance in Nonobese Patients with Polycystic Ovary Syndrome

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Hormone Research in Paediatrics

• Publication date

  2001-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000049972PMID 11509861
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Effects of metformin on insulin resistance and on ovarian steroidogenesis in women with polycystic ovary syndrome].

  2001cited by this paper
• Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells.

  2000cited by this paper
• Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.

  1999cited by this paper
• The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome

  1999cited by this paper
• Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders.

  1999cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Selective Insulin Resistance in the Polycystic Ovary Syndrome*

  1999cited by this paper
• Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

  1999cited by this paper
• [Insulin resistance: from clinical diagnosis to molecular genetics. Implications in diabetes mellitus].

  1999cited by this paper
• Insulin action in the normal and polycystic ovary.

  1999cited by this paper
• The treatment of insulin resistance does not improve adrenal cytochrome P450c17alpha enzyme dysregulation in polycystic ovary syndrome.

  1999cited by this paper
• Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

  1998cited by this paper
• A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.

  1998cited by this paper
• Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications.

  1998cited by this paper
• Polycystic ovary syndrome: a new direction in treatment

  1998cited by this paper
• Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary Syndrome

  1997cited by this paper
• Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.

  1997cited by this paper
• Polycystic ovary syndrome.

  1997cited by this paper
• Troglitazone Improves Defects in Insulin Action , Insulin Secretion , Ovarian Steroidogenesis , and Fibrinolysis in Women with Polycystic Ovary Syndrome *

  1997cited by this paper
• Gonadotropin levels in women with polycystic ovary syndrome: Their relationship to body weight and insulin levels

  1996cited by this paper
• Can metformin reduce insulin resistance in polycystic ovary syndrome?

  1996cited by this paper
• Insulin resistant and non-resistant polycystic ovary syndrome represent two clinical and endocrinological subgroups.

  1996cited by this paper
• The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

  1996cited by this paper
• Endocrinology: Insulin resistant and non-resistant polycystic ovary syndrome represent two clinical and endocrinological subgroups

  1995cited by this paper
• Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Insulin secretion in obese and non-obese women with polycystic ovary syndrome and its relationship with hyperandrogenism.

  1995cited by this paper
• Metabolic regulation of androgen production by human thecal cells in vitro.

  1995cited by this paper
• Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.

  1994cited by this paper
• Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.

  1994cited by this paper
• Increased luteinizing hormone and alpha-subunit secretion in women with hyperandrogenic anovulation.

  1993cited by this paper
• Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin.

  1993cited by this paper
• Interface between Extra‐ and Intraovarian Factors in Polycystic Ovarian Syndrome

  1993cited by this paper
• Heated dorsal hand vein sampling for metabolic studies: a reappraisal.

  1992cited by this paper
• Detection of functional ovarian hyperandrogenism in women with androgen excess.

  1992cited by this paper
• A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.

  1991cited by this paper
• Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects.

  1991cited by this paper
• Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome.

  1990cited by this paper
• Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin.

  1988cited by this paper
• Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells.

  1988cited by this paper
• Insulin and C-Peptide Levels in Obese Patients with Polycystic Ovaries

  1982cited by this paper
• Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells.

  1981cited by this paper
• Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.

  1980cited by this paper
• Characterization of hyperandrogenism with insulin-resistant diabetes type A.

  1980cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• Clinical Findings and Hormonal Responses in Patients With Polycystic Ovarian Disease With Normal Versus Elevated LH Levels

  1976cited by this paper

• A cross-sectional exploratory study of rat sarcoma (Ras) activation in non-obese women with and without polycystic ovary syndrome

  2026cites this paper
• Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation

  2025cites this paper
• The overlooked mental health burden of polycystic ovary syndrome: neurobiological insights into PCOS-related depression.

  2025cites this paper
• Effects of cryptotanshinone in treatment of polycystic ovary syndrome in rats: a systematic review and meta-analysis

  2025cites this paper
• Aerobic training effects on knee joint laxity and estrogen levels in post-menopausal women with type 2 diabetes: a randomized controlled trial

  2025cites this paper
• CRISPR as a Tool to Uncover Gene Function in Polycystic Ovary Syndrome: A Literature Review of Experimental Models Targeting Ovarian and Metabolic Genes

  2025cites this paper
• Nonobese PCOS Compared to Obese PCOS Have Similar Clinical Presentation, Hormonal Profile, and Insulin Resistance

  2025cites this paper
• Relation Between Obesity and Type 2 Diabetes: Evolutionary Insights, Perspectives and Controversies

  2024cites this paper
• Impact of puberty, sex determinants and chronic inflammation on cardiovascular risk in young people

  2023cites this paper
• A Study of Hormonal and Anthropometric Parameters in Polycystic Ovarian Syndrome

  2023cites this paper
• INSULIN RESISTANCE IN POLYCYSTIC OVARY SYNDROME

  2023cites this paper
• Impose of KNDy/GnRH neural circuit in PCOS, ageing, cancer and Alzheimer's disease: StAR actions in prevention of neuroendocrine dysfunction.

  2023cites this paper
• Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndrome

  2023cites this paper
• Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance

  2023cites this paper
• Evaluation of Biochemical and Hematological Parameters in Polycystic Ovarian Syndrome Among Urban College Girls

  2022cites this paper
• Selected Toxicity Study on Ethanolic Extract of Ocimum gratissimum (Linn.) Leaves in Letrozole-Induced Polycystic Ovarian Syndrome in Wistar Rats

  2022cites this paper
• Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review

  2022cites this paper
• How obesity affects female fertility

  2022cites this paper
• Predictors of insulin resistance among women with acne vulgaris and polycystic ovarian syndrome presenting to a tertiary care hospital in North India

  2021cites this paper
• Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome

  2021cites this paper
• Assessment of Metabolic Profile in Relation with Polycystic Ovary Syndrome

  2021cites this paper
• Berberine Phospholipid Is an Effective Insulin Sensitizer and Improves Metabolic and Hormonal Disorders in Women with Polycystic Ovary Syndrome: A One-Group Pretest–Post-Test Explanatory Study

  2021cites this paper
• Urinary Metabolites Reveal Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Syndrome (PCOS)

  2021cites this paper
• Заключение совещания экспертов «Обоснование применения средств на основе инозитола у пациенток с нарушениями менструального цикла»

  2020cites this paper
• Obesity represents a strong pathogenetic link with the pathology of pregnancy and childbirth

  2020cites this paper
• Impact of interlukin-6 on central obesity measures in women with polycystic ovarian syndrome

  2020cites this paper
• Chemerin level in a sample of Egyptian females with PCOS and its relation to insulin resistance

  2020cites this paper
• Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome

  2019cites this paper
• Female infertility: which role for obesity?

  2019cites this paper
• Omentin‐1 level in adolescents with polycystic ovarian syndrome

  2019cites this paper
• Mechanisms of Insulin Resistance Formation in Polycystic Ovarian Disease and Therapeutic Effects from Myo Inositol

  2019cites this paper
• Morning blood pressure surge and its relation to insulin resistance in patients of reproductive age with polycystic ovary syndrome

  2018cites this paper
• Nutraceutical prospective: The synergetic mechanism of action of inositols and resveratrol on metabolic syndrome

  2018cites this paper
• Increased risk of polycystic ovary syndrome (PCOS) associated with CC genotype of miR-146a gene variation

  2018cites this paper
• Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis.

  2017cites this paper
• Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance

  2017cites this paper
• Inositol(s) from Bench to Bedside in Endocrinology and Gynecology

  2017cites this paper
• Decreased circulating levels of betatrophin in Chinese women with polycystic ovary syndrome

  2017cites this paper
• Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols

  2017cites this paper
• Polycystic ovary syndrome and nonalcoholic fatty liver disease

  2017cites this paper
• Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

  2017cites this paper
• COMPARISON OF FINASTERIDE, METFORMIN, AND FINASTERIDE PLUS METFORMIN IN PCOS.

  2017cites this paper
• High-Fat, High-Sugar Diet Disrupts the Preovulatory Hormone Surge and Induces Cystic Ovaries in Cycling Female Rats

  2017cites this paper
• Clinical Presentation of Polycystic Ovary Syndrome among Saudi Arabian Women – Jeddah – Saudi Arabia

  2017cites this paper
• High-fat high-sugar diet induces polycystic ovary syndrome in a rodent model†

  2017cites this paper
• MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease.

  2017cites this paper
• Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies

  2016cites this paper
• Inositol Treatment and ART Outcomes in Women with PCOS

  2016cites this paper
• Genetic variations in the 3'-untranslated region of SLC18A2 are associated with serum FSH concentration in polycystic ovary syndrome patients and regulate gene expression in vitro.

  2016cites this paper
• Physiological role and clinical utility of inositols in polycystic ovary syndrome.

  2016cites this paper
• Prevalence, etiology and management of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome.

  2016cites this paper
• Study of Insulin Resistance in Polycystic Ovarian Syndrome

  2016cites this paper
• Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study.

  2015cites this paper
• Polycystic Ovary Syndrome and Insulin: Our Understanding in the Past, Present and Future

  2015cites this paper
• Polycystic ovarian syndrome and insulin resistance: a North Indian study

  2015cites this paper
• Chapter 133 – Hyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome

  2015cites this paper
• Insulin Resistance in Non-Obese Polycystic Ovary Syndrome Subjects and Relation with Family History of Diabetes Mellitus

  2015cites this paper
• A population-based study of the relationship between idiopathic hirsutism and metabolic disturbances

  2015cites this paper
• Insulin resistance and lipid profile in polycystic ovary syndrom

  2015cites this paper
• Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth

  2014cites this paper
• Assessment of insulin resistance in lean women with polycystic ovary syndrome.

  2014cites this paper
• Progressive Resistance Training in Polycystic Ovary Syndrome: Can Pumping Iron Improve Clinical Outcomes?

  2014cites this paper
• 3 – The health consequences of obesity

  2014cites this paper
• Insulin Dynamics in Young Women with Polycystic Ovary Syndrome and Normal Glucose Tolerance across Categories of Body Mass Index

  2014cites this paper
• Elevated serum thioredoxin‐interacting protein in women with polycystic ovary syndrome is associated with insulin resistance

  2014cites this paper
• Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis.

  2013cites this paper
• Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case–control study

  2013cites this paper
• Is Insulin Resistance an Intrinsic Defect in Asian Polycystic Ovary Syndrome?

  2013cites this paper
• Polycystic ovary syndrome: clinical presentation in normal-weight compared with overweight adolescents.

  2013cites this paper
• Molecular Interactions of Polycystic Ovarian Syndrome (PCOS) with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease

  2013cites this paper
• Effect of non-esterified fatty acids on insulin resistance and cardiovascular risk in polycystic ovary syndrome

  2013cites this paper
• The Effect of Atorvastatin, Metformin or Their Combination in Unmarried Women with Polycystic Ovary Syndrome

  2013cites this paper
• Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis.

  2013cites this paper
• Serum brain natriuretic peptide and C-reactive protein levels in adolescent with polycystic ovary syndrome

  2012cites this paper
• Age and BMI Adjusted Comparison of Reproductive Hormones in PCOS

  2012cites this paper
• Long-term reproductive and metabolic consequences of PCOS.

  2012cites this paper
• Evaluation of various insulin sensitivity indices in lean idiopathic hirsutism patients.

  2012cites this paper
• Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non‐alcoholic fatty liver disease

  2011cites this paper
• Polycystic ovary syndrome and associated metabolic features in indigenous women in the Northern Territory.

  2011cites this paper
• Plasma apelin levels in patients with polycystic ovary syndrome.

  2011cites this paper
• State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS)

  2011cites this paper
• Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome--a long term follow-up.

  2011cites this paper
• Effects of Apples and Exercise on Clinical Parameters of Metabolic Syndrome in Women with Polycystic Ovary Syndrome

  2010cites this paper
• Leading causes of mortality of Asian Indians in California.

  2010cites this paper
• Metabolic abnormalities in adolescents with polycystic ovary syndrome in south china

  2010cites this paper
• Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies.

  2010cites this paper
• Insulin resistance and overweight-obese women with polycystic ovary syndrome

  2010cites this paper
• Polycystic ovary syndrome

  2010cites this paper
• Omental fat expression of adiponectin and adiponectin receptors in non-obese women with PCOS: a preliminary study.

  2009cites this paper
• Beta cell function and insulin sensitivity in women with polycystic ovary syndrome: Influence of the family history of type 2 diabetes mellitus

  2009cites this paper
• Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.

  2009cites this paper
• Iron Indices are higher in Women with Polycystic Ovary Syndrome than Healthy Control.

  2009cites this paper
• The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome

  2009cites this paper
• Trials of dietary intervention and impact on key features in overweight / obese women with polycystic Study Patients Duration Intervention Weight loss

  2009cites this paper
• Neuroendocrine Dysfunction in PCOS: A Critique of Recent Reviews

  2008cites this paper
• Basic infertility including polycystic ovary syndrome.

  2008cites this paper
• Are the available experimental models of type 2 diabetes appropriate for a gender perspective?

  2008cites this paper
• EL SÍNDROME DE OVARIOS POLIQUÍSTICOS Y SU ROL POTENCIAL EN LA PATOGÉNESIS DE LA HIPERTENSIÓN INDUCIDA POR EL EMBARAZO Polycystic ovary syndrome and its potential role in the pathogenesis of pregnancy-induced hypertension

  2007cites this paper
• The pathogenetic enigma of polycystic ovary syndrome.

  2007cites this paper
• Polycystic Ovary Syndrome: Long-term health consequences of polycystic ovary syndrome

  2007cites this paper